Effect of Hypochlorite Sodium 0.005% in treatment of Acne

Hypochlorite Sodium 0.005% versus placebo in treatment of mild to moderate Acne; A randomized double blind clinical control

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200701047976N1

Enrollment

Registered

2020-07-14

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group: Solution of Hypochlorite sodium 0.005% was prepared by pharmacist from Hypochlorite sodium 6%. In this study, the concentration of solution was determined according

each bottle has specific code showing its content. Only the pharmacist is aware about these codes. The patients received Hypochlorite sodium 0.005% administered topically on the right or left side of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild to moderate Acne Vulgaris diagnosed by dermatologist

Exclusion criteria

Exclusion criteria: Patients with symptoms such as secondary Acne caused by lactation Dermatology condition in addition to Acne Patients who had taken drugs such as Isotretinoin or systemic/topical antibiotics within the last two months Allergy to Hypochlorite Sodium

Design outcomes

Primary

Measure	Time frame
Evaluation of Acne remission on the basis of changes in the number of Papules and Pustules. Timepoint: Initiation of study(before starting the treatment), 14 days and 28 days after starting the treatment. Method of measurement: Counting the number of Papules and Pustules.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hadibarhaghtalab

Shiraz University of Medical Sciences

Maryam_hadibarhaghtalab@yahoo.com+98 71 3622 3919

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026